Resorbable Vascular Scaffolds Global Market Report 2025

The resorbable vascular scaffolds market size has grown rapidly in recent years. It will grow from $0.46 billion in 2024 to $0.52 billion in 2025 at a compound annual growth rate (CAGR) of 12.9%. The growth during the historic period can be attributed to the increasing prevalence of cardiovascular diseases, rising consumer health awareness, a growing incidence of coronary artery disease (CAD), the increasing adoption of minimally invasive procedures, and the rising prevalence of diabetes.

The resorbable vascular scaffolds market size is expected to see rapid growth in the next few years. It will grow to $0.83 billion in 2029 at a compound annual growth rate (CAGR) of 12.6%. The growth during the forecast period can be attributed to the increasing risk of coronary artery disease (CAD) and peripheral artery disease (PAD) in the geriatric population, rising funding for research and development (R&D) in surgical procedures, a growing aging population, increasing healthcare expenditure, and the rising prevalence of coronary artery disease. Key trends expected during this period include a shift toward drug-eluting devices for angioplasty, technological advancements and product innovations, and continuous improvements in stent and diagnostic technologies.

The increasing prevalence of cardiovascular diseases is expected to drive the growth of the resorbable vascular scaffolds market. These diseases are influenced by factors such as poor lifestyle choices, aging, high blood pressure, high cholesterol, diabetes, smoking, and genetic predispositions. Resorbable vascular scaffolds are transforming cardiovascular treatment by providing temporary structural support to restore blood flow while gradually dissolving, minimizing long-term complications associated with permanent implants, and promoting natural vessel healing and functionality. For example, in September 2024, the Minnesota Department of Health, a US-based state agency, reported that in 2023, 4% of adults in Minnesota approximately 180,000 people had experienced a heart attack. Additionally, heart disease accounted for around 17% of all deaths in the state, resulting in 8,972 fatalities in 2022. Consequently, the rising prevalence of cardiovascular diseases is fueling the growth of the resorbable vascular scaffolds market.

Leading companies in the resorbable vascular scaffolds market are developing magnesium scaffolds to enhance biocompatibility and provide superior mechanical support. Magnesium scaffolds facilitate natural vessel healing while reducing inflammation and complications associated with conventional polymer-based scaffolds. In March 2024, Biotronik, a Germany-based medical device company, received FDA breakthrough device designation for its Freesolve below-the-knee resorbable magnesium scaffold (BTK RMS). Designed for patients with chronic limb-threatening ischemia (CLTI), Freesolve RMS offers an advanced treatment option for below-the-knee (BTK) interventions. It incorporates BIOmag magnesium alloy and Orsiro drug-eluting stent (DES) coating technology, improving safety, deliverability, and vessel support while providing short-term structural reinforcement during the healing process.

In April 2023, Abbott Laboratories, a US-based medical device company, acquired Cardiovascular Systems Inc. for an undisclosed amount. This acquisition allows Abbott to expand its vascular portfolio, enhance treatment options, and improve care for patients with peripheral and coronary artery disease. Cardiovascular Systems Inc. (CSI) is a US-based medical device company specializing in developing innovative atherectomy systems used for treating peripheral and coronary artery diseases.

Major players in the resorbable vascular scaffolds market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Getinge Group, Biotronik, LivaNova plc, Lepu Medical Technology, Gore Medical, Biosensors International, Blue Medical, Reva Medical, Elixir Medical, S3V Vascular Technologies, Amaranth Medical Inc., Meril Life Sciences Pvt. Ltd., Arterius Limited, Zorion Medical, Kyoto Medical Planning Co. Ltd., and ICON Interventional Systems.

North America was the largest region in the resorbable vascular scaffolds market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in resorbable vascular scaffolds report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the resorbable vascular scaffolds market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Resorbable vascular scaffolds are medical devices designed to treat vascular diseases by temporarily supporting blood vessels and gradually dissolving once their function is complete. These scaffolds help restore normal blood flow and promote natural vessel healing, offering a safer and more effective alternative to permanent stents by reducing long-term complications.

The main product designs of resorbable vascular scaffolds include multilumen and single-lumen types. Multilumen resorbable vascular scaffolds are advanced bioresorbable devices with multiple channels that enhance support, improve blood flow, and facilitate vessel healing in complex vascular conditions. These scaffolds are made from materials such as poly-glycolic acid, poly-l-lactic acid, and poly-l-lactic-co-glycolic acid and are deployed using balloon-expandable or self-expandable techniques. They are primarily used in treating coronary artery disease, peripheral vascular disease, and pulmonary artery disease, serving end users such as ambulatory surgical centers, hospitals, and specialty clinics.

The resorbable vascular scaffolds market research report is one of a series of new reports that provides resorbable vascular scaffolds market statistics, including resorbable vascular scaffolds industry global market size, regional shares, competitors with a resorbable vascular scaffolds market share, detailed resorbable vascular scaffolds market segments, market trends and opportunities, and any further data you may need to thrive in the resorbable vascular scaffolds industry. This resorbable vascular scaffolds market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The resorbable vascular scaffolds market consists of sales of resorbable scaffold systems, resorbable scaffold delivery devices, and bioresorbable stents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.